NasdaqGM - Delayed Quote USD
CAMP4 THERAPEUTICS CORPORATION (CAMP)
2.0500
+0.0600
+(3.02%)
At close: April 25 at 4:00:02 PM EDT
2.0500
0.00
(0.00%)
After hours: April 25 at 4:05:14 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| 5AM PARTNERS VI, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| AH EQUITY PARTNERS BIO I, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| ENAVATE SCIENCES GP, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| HOLTZMAN STEVEN H Director | Conversion of Exercise of derivative security | Oct 15, 2024 | 108,946 |
| MANDEL-BREHM JOSH Chief Executive Officer | Conversion of Exercise of derivative security | Oct 15, 2024 | 272,357 |
| NASHAT AMIR H. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| NORTHPOND VENTURES II GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| POLARIS MANAGEMENT CO. VII, L.L.C Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| SCHWAB ANDREW J. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| YOUNG RICHARD A Director | Conversion of Exercise of derivative security | Oct 15, 2024 | 154,859 |
Related Tickers
MBX MBX Biosciences, Inc.
9.17
-1.08%
UPB Upstream Bio, Inc.
8.39
-6.36%
BOLD Boundless Bio, Inc.
1.4700
-4.55%
SION Sionna Therapeutics, Inc.
12.14
-3.65%
ARTV Artiva Biotherapeutics, Inc.
2.4700
+0.82%
CYCN Cyclerion Therapeutics, Inc.
3.2500
+7.97%
ONC.L Oncimmune Holdings plc
1.1400
-4.20%
ANTI Antigenics, Inc.
0.0000
0.00%
LSTA Lisata Therapeutics, Inc.
2.5300
+2.43%
SILO Silo Pharma, Inc.
1.1500
+0.88%